Recent advancements in circulating nucleic acids, including cf-DNA and cf-RNA, have improved diagnostics and monitoring ...
Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...
Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...
SINGAPORE: A national programme aimed at positioning Singapore at the forefront of RNA science has been officially launched ...
A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...
Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.
SINGAPORE – A new programme has been launched in Singapore to formally study the applications of ribonucleic acid (RNA) in vaccine development, as well as in disease therapy and prevention ...
A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop resistance to therapy.
A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...
A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...
Werner held roles at Bristol Myers Squibb, AstraZeneca and Novartis before landing at Alltrna, where she works to develop tRNA-based treatments for a range of diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback